Rate My Professor Robert Dupuis

Dupuis's research focuses on clinical pharmacology and drug metabolism of immunosuppressants in organ transplant recipients, including drug disposition, pharmacogenomics, adverse effects, outcomes, and care enhancement for transplant patients. He has authored chapters on kidney and liver transplantation and solid organ transplantation in multiple editions of Applied Therapeutics: The Clinical Use of Drugs (6th to 12th editions, 1995-2023) and contributed to PharmPrep and other texts. Key publications include "Reduced dosing versus standard dosing valganciclovir for prophylaxis of cytomegalovirus in high-risk abdominal transplant recipients" (Clinical Transplantation, 2023), "Alemtuzumab in renal retransplantation - transplant outcomes and associated infections" (Transplantation Proceedings, 2021), "Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant patients" (Clinical Transplantation, 2021), and "Evolution of the Role of the Transplant Pharmacist on the Multidisciplinary Transplant Team" (American Journal of Transplantation, 2011). His contributions have advanced transplant pharmacotherapy practices. Dupuis has received numerous awards, including the Fred M. Eckel Pharmacy Leadership Award (2023), Excellence in Teaching Awards (2006, 2007, 2017), Fellowship in the American College of Clinical Pharmacy (2008), and Instructor or Preceptor of the Year from UNC School of Pharmacy PharmD classes multiple times (1987-2017).